Clinical manifestations and laboratory features of acute parvovirus infection in children with oncohematological diseases (Review of literature and clinical case reports)

Cover Page

Cite item

Full Text

Abstract

Parvovirus B19 (РВ19) is an ubiquitous single strand DNA-virus, which in healthy persons causes the so-called fifth disease -benign infectious exanthema. However, in patients with disturbed erythropoiesis or immune deficiencies PB19 infection can lead to potentially life-threatening syndromes. Three pediatric patients (females) with primary PB19 infection are described. One patient with hereditary spherocytosis developed a classical transitory aplastic crisis which required several blood transfusions. In a second patient with acquired aplastic anemia and high titers of PB19 in peripheral blood, long-lasting fewer, and rash hematopoietic stem cell transplantation had to be postponed for 2 weeks because of the risk of graft function suppression. In a third patient high titers of PB19 in bone marrow resulted in long-lasting aplasia and delay of scheduled intensive chemotherapy and hence, in relapse of underlying acute myeloid leukemia. Importantly that 2 of 3 patients (the second and the third one) received platelet transfusions from the same donor. So far, the problem of diagnosis, treatment and prevention of PB19 infection in patients with hematological/oncological diseases remains unresolved and needs further discussion.

About the authors

A. A. Roppelt

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Author for correspondence.
Email: roppelt_anna@mail.ru
Russian Federation

A. P. Vasilyeva

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: anna.vasilieva1988@gmail.com
Russian Federation

I. I. Kalinina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: irina.kalinina@fccho-moscow.ru
Russian Federation

D. D. Baidildina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: ogdk@yandex.ru
Russian Federation

E. V. Suntsova

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: ogdk@yandex.ru
Russian Federation

T. Yu. Salimova

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: ogdk@yandex.ru
Russian Federation

U. N. Petrova

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: ogdk@yandex.ru
Russian Federation

I. V. Fisyun

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: ogdk@yandex.ru
Russian Federation

E. V. Raikina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: e_raikina@inbox.ru
Russian Federation

O. V. Goronkova

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: ogdk@yandex.ru
Russian Federation

M. A. Maschan

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: mmaschan@yandex.ru
Russian Federation

A. A. Maschan

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: amaschan@mail.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Roppelt A.A., Vasilyeva A.P., Kalinina I.I., Baidildina D.D., Suntsova E.V., Salimova T.Y., Petrova U.N., Fisyun I.V., Raikina E.V., Goronkova O.V., Maschan M.A., Maschan A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.